Eastern Podiatry Llc in Millsboro, DE - Podiatrist

Eastern Podiatry Llc is a Podiatrist based in Millsboro, Delaware. Eastern Podiatry Llc is licensed to practice in * (Not Available) (license number ) and their current practice location is 231 S Washington St, Millsboro, Delaware. It can be reached at their office (for appointments etc.) via phone at (718) 972-5000.

NPI number for Eastern Podiatry Llc is 1043517758 and their current mailing address is 1335 54th St, Brooklyn, New York. Eastern Podiatry Llc does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1043517758.

Contact Information

	Eastern Podiatry Llc
	231 S Washington St, Millsboro, DE 19966-1236
	(718) 972-5000
	(718) 972-3774

Healthcare Provider's Profile

Full Name	Eastern Podiatry Llc
Type	Facility
Speciality	Podiatrist
Location	231 S Washington St, Millsboro, Delaware
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1043517758
Provider Enumeration Date: 02/15/2011
Last Update Date: 02/15/2011

Medical Identifiers

Medical identifiers for Eastern Podiatry Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043517758	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213E00000X	Podiatrist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eastern Podiatry Llc is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Eastern Podiatry Llc 1335 54th St, Brooklyn, NY 11219-4220 Ph: (718) 972-5000	Eastern Podiatry Llc 231 S Washington St, Millsboro, DE 19966-1236 Ph: (718) 972-5000

News Archive

Dormant HIV reservoirs could be killed with RNA switch

Researchers from the University of California San Diego School of Medicine have found cellular triggers within the immune cells that could be controlled in order to kill dormant HIV-1 reservoirs in individuals with HIV-1.

Ranbaxy receives tentative approval to manufacture Amlodipine Besylate tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).

WIN Consortium proposes unique alliance to fight cancer

WIN Consortium proposes a unique alliance to fight cancer and invites you to join the 3rd annual symposium: Gateways to efficacy of cancer diagnostics and therapeutics to be held on 6th to 8th of July at the Palais des Congrès in Paris, France.

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Depomed, Inc. today announced that Janssen Pharmaceuticals, Inc., has licensed rights to Depomed's Acuform gastric retentive drug delivery technology.

Eastern Podiatry Llc - Podiatrist in Millsboro, DE